Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
CC transcript
AMGEN INC (AMGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 9% stake in Amgen Inc.
02/07/2023 SC 13G/A BlackRock Inc. reports a 9.1% stake in AMGEN INC
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2022 SC 13G/A Capital Research Global Investors reports a 3.9% stake in Amgen Inc.
02/10/2022 SC 13G/A STATE STREET CORP reports a 5.4% stake in AMENDED FILING AMGEN INC
02/09/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/31/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021 SC 13G/A Capital Research Global Investors reports a 5.5% stake in Amgen Inc.
02/10/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/05/2021 SC 13G/A AMGEN INC has filed a Schedule 13D for Akero Therapeutics, Inc.
02/05/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/07/2020 SC 13G/A AMGEN INC reports a 2.6% stake in KEZAR LIFE SCIENCES, INC.
02/07/2020 SC 13G/A FMR LLC reports a 4.1% stake in AMGEN INC
02/05/2020 SC 13G/A BlackRock Inc. reports a 7.8% stake in AMGEN INC
02/13/2019 SC 13G/A Capital Research Global Investors reports a 5.5% stake in Amgen Inc.
02/13/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2019 SC 13G/A BlackRock Inc. reports a 7.2% stake in AMGEN INC
02/11/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/28/2018 SC 13G/A AMGEN INC reports a 4.4% stake in ADVAXIS, INC.
02/13/2018 SC 13G/A FMR LLC reports a 7.1% stake in AMGEN INC
02/12/2018 SC 13G/A VANGUARD GROUP INC reports a 7.2% stake in Amgen Inc
01/29/2018 SC 13G/A BlackRock Inc. reports a 6.8% stake in AMGEN INC
08/02/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2017 SC 13G/A Capital Research Global Investors reports a 8.8% stake in Amgen Inc.
02/09/2017 SC 13G/A AMGEN INC reports a 6.5% stake in Amgen Inc
02/07/2017 SC 13G/A AMGEN INC has filed a Schedule 13D for UNILIFE CORPORATION
02/07/2017 SC 13G/A Advaxis, Inc. reports a 7.6% stake in ADVAXIS, INC.
02/07/2017 SC 13G/A AMGEN INC reports a 4.9% stake in ATARA BIOTHERAPEUTICS, INC.
01/19/2017 SC 13G/A AMGEN INC reports a 6.8% stake in AMGEN INC
05/03/2013 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
02/13/2012 SC 13G/A AMGEN INC reports a 5.5% stake in AMGEN INC
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy